-
公开(公告)号:US20040141922A1
公开(公告)日:2004-07-22
申请号:US10722075
申请日:2003-11-26
申请人: NYCOMED IMAGING AS
发明人: Jo Klaveness , Pal Rongved , Anders Hogset , Helge Tolleshaug , Anne Naevestad , Halldis Hellebust , Lars Hoff , Alan Cuthbertson , Dagfinn Lovhaug , Magne Solbakken
IPC分类号: A61K049/00 , A61K038/00
CPC分类号: A61K51/1255 , A61K47/542 , A61K47/62 , A61K47/6925 , A61K49/0002 , A61K49/0043 , A61K49/0047 , A61K49/0054 , A61K49/0056 , A61K49/0058 , A61K49/0091 , A61K49/223 , A61K51/088 , A61K51/1227 , Y10S977/928
摘要: Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, having reporters comprising gas-filled microbubbles stabilised by monolayers of film-forming surfactants, the reporter being coupled or linked to at least one vector.
摘要翻译: 靶向诊断和/或治疗活性剂,例如 超声造影剂,具有包含通过成膜表面活性剂的单层稳定的充气微泡的记者,所述报告基团与至少一个载体偶联或连接。
-
公开(公告)号:US20020102217A1
公开(公告)日:2002-08-01
申请号:US09925715
申请日:2001-08-10
申请人: Nycomed Imaging AS
发明人: Jo Klaveness , Pal Rongved , Anders Hogset , Helge Tolleshaug , Alan Cuthbertson , Aslak Godal , Lars Hoff , Geir Gogstad , Klaus Bryn , Anne Naevestad , Dagfinn Lovhaug , Halldis Hellebust , Magne Solbakken
IPC分类号: A61B008/00
CPC分类号: A61K51/1255 , A61K47/542 , A61K47/62 , A61K47/6925 , A61K49/0002 , A61K49/0043 , A61K49/0047 , A61K49/0054 , A61K49/0056 , A61K49/0058 , A61K49/0091 , A61K49/223 , A61K51/065 , A61K51/1227 , Y10S977/928 , Y10S977/929 , Y10S977/93
摘要: Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.
摘要翻译: 靶向诊断和/或治疗活性剂,例如 超声造影剂,其包含在包含含气体或气体产生材料的报道分子的含水载体液体中的悬浮液,所述试剂能够与靶形成至少两种结合对。
-
公开(公告)号:US20020102215A1
公开(公告)日:2002-08-01
申请号:US09765614
申请日:2001-01-22
申请人: NYCOMED IMAGING AS
发明人: Jo Klaveness , Pal Rongved , Anders Hogset , Helge Tolleshaug , Anne Naevestad , Halldis Hellebust , Lars Hoff , Alan Cuthbertson , Dagfinn Lovhaug , Magne Solbakken
IPC分类号: A61K049/00 , A61K048/00
CPC分类号: A61K51/1255 , A61K47/542 , A61K47/62 , A61K47/6925 , A61K49/0002 , A61K49/0043 , A61K49/0047 , A61K49/0054 , A61K49/0056 , A61K49/0058 , A61K49/0091 , A61K49/223 , A61K51/088 , A61K51/1227 , Y10S977/928
摘要: Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, having reporters comprising gas-filled microbubbles stabilized by monolayers of film-forming surfactants, the reporter being coupled or linked to at least one vector.
摘要翻译: 靶向诊断和/或治疗活性剂,例如 超声造影剂,具有包含通过成膜表面活性剂的单层稳定的充气微泡的记者,所述报告基团与至少一个载体偶联或连接。
-
公开(公告)号:US20030059373A1
公开(公告)日:2003-03-27
申请号:US10072655
申请日:2002-02-08
申请人: Nycomed Imaging AS
发明人: Jo Klaveness , Pal Rongved , Lars Stubberud
IPC分类号: A61K049/04
CPC分类号: A61K49/1818 , A61K49/1821 , A61K49/223 , A61K49/225
摘要: Contrast agents comprising microbubble-generating carbohydrate microparticles having a surfactant admixed within the microparticulate structure, with the proviso that the surfactant is not a C10-20 fatty acid, are disclosed. Processes for preparing contrast agents also are disclosed.
摘要翻译: 公开了包含在微粒结构内具有表面活性剂的产生微泡的碳水化合物微粒的对比剂,前提是表面活性剂不是C10-20脂肪酸。 还公开了制备造影剂的方法。
-
公开(公告)号:US20010022963A1
公开(公告)日:2001-09-20
申请号:US09732917
申请日:2000-12-11
发明人: Jo Klaveness , Bjorn Fuglass , Pal Rongved , Edvin Johannesen , Paul Mark Henrichs , Wolfgang Hans Heinrich Gunther , Edward Richard Bacon , John Luke Toner , Gregory Lynn McIntire , Vinay C. Desai
IPC分类号: A61B005/00
CPC分类号: B82Y5/00 , A61K49/001 , A61K49/0015 , A61K49/0032 , A61K49/0034 , A61K49/0043 , A61K49/0052 , A61K49/0078 , A61K49/0082 , A61K49/0084 , A61K49/0433 , A61K49/0461 , A61K49/0466 , A61K49/0485 , A61K49/223 , A61K49/227
摘要: The present invention relates to the use of particulate materials as contrast agents in in vivo light imaging.
摘要翻译: 本发明涉及在体内光成像中使用颗粒材料作为造影剂。
-
公开(公告)号:US20040131549A1
公开(公告)日:2004-07-08
申请号:US10640504
申请日:2003-08-13
申请人: Nycomed Imaging AS.
发明人: Jo Klaveness , Pal Rongved , Per Strande
IPC分类号: A61K049/00
CPC分类号: A61K49/225 , A61K47/26 , A61K47/42 , A61K49/223 , C07C69/96
摘要: The invention relates to ultrasound contrast agents comprising vesicles comprising a protein capable of formation of gas-containing vesicles, wherein the vesicles contain gas which comprises sulphur hexafluoride or a low molecular weight fluorinated hydrocarbon. These contrast agents exhibit stability in vivo upon administration so as to permit ultrasound visualization while allowing rapid subsequent elimination from the system.
摘要翻译: 本发明涉及包含囊泡的超声波造影剂,其包含能形成含气囊泡的蛋白质,其中囊泡含有包含六氟化硫或低分子量氟化烃的气体。 这些造影剂在施用时在体内表现出稳定性,以便允许超声可视化,同时允许从系统快速随后的消除。
-
公开(公告)号:US20030104359A1
公开(公告)日:2003-06-05
申请号:US10294598
申请日:2002-11-15
申请人: NYCOMED IMAGING AS
发明人: Alan Cuthbertson , Dagfinn Lovhaug , Hege Fjerdingstad , Pal Rongved , Magne Solbakken , Aslak Godal
IPC分类号: C12Q001/70 , C12Q001/68 , G01N033/53 , G01N033/554 , G01N033/569 , C12M001/34
CPC分类号: G01N33/5432 , A61K49/223 , B03D1/00 , B03D1/02 , B03D1/14 , B03D1/247 , B03D2203/003 , C07K16/1271 , C07K16/2821 , C07K16/2854 , C07K16/2896 , G01N2405/04
摘要: Separation of target material from a liquid sample is achieved by coupling the target to targetable encapsulated gas microbubbles, allowing the microbubbles and coupled target to float to the surface of the sample to form a floating microbubble/target layer, and separating this layer from the sample. In a positive separation process the microbubbles are then removed from the target, e.g. by bursting. In a negative separation process target-free sample material is recovered following separation of the floating layer. The method may also be used diagnostically to detect the presence of a disease marker in a sample. Novel separation apparatus is also described.
摘要翻译: 目标材料与液体样品的分离是通过将目标物与可靶向包封的气体微泡耦合来实现的,允许微泡和偶联的目标物漂浮到样品表面以形成浮动微泡/目标层,并将该层与样品分离 。 在正分离过程中,然后从目标物中除去微泡。 通过爆裂。 在负分离过程中,在浮选层分离后回收无目标样品材料。 该方法也可以在诊断上用于检测样品中疾病标志物的存在。 还描述了新颖的分离装置。
-
公开(公告)号:US20030031629A1
公开(公告)日:2003-02-13
申请号:US10071863
申请日:2002-02-08
申请人: Nycomed Imaging AS
发明人: Jo Klaveness , Pal Rongved , Per Strande
IPC分类号: A61K049/00
CPC分类号: A61K49/225 , A61K47/26 , A61K47/42 , A61K49/223 , C07C69/96
摘要: The invention relates to ultrasound contrast agents comprising vesicles comprising a protein capable of formation of gas-containing vesicles, wherein the vesicles contain gas which comprises sulphur hexafluoride or a low molecular weight fluorinated hydrocarbon. These contrast agents exhibit stability in vivo upon administration so as to permit ultrasound visualization while allowing rapid subsequent elimination from the system.
摘要翻译: 本发明涉及包含囊泡的超声波造影剂,其包含能形成含气囊泡的蛋白质,其中囊泡含有包含六氟化硫或低分子量氟化烃的气体。 这些造影剂在施用时在体内表现出稳定性,以便允许超声可视化,同时允许从系统快速随后的消除。
-
公开(公告)号:US20020172643A1
公开(公告)日:2002-11-21
申请号:US09927919
申请日:2001-08-10
申请人: Nycomed Imaging AS
发明人: Jo Klaveness , Hanno Priebe , Pal Rongved , Lars Stubberud
IPC分类号: A61K049/00
CPC分类号: A61K49/223
摘要: The present invention provides contrast agents for use in diagnostic ultrasound studies comprising microbubbles of gas or a gas precursor encapsulated by non-proteinaceous crosslinked or polymerised amphiphilic moieties.
摘要翻译: 本发明提供用于诊断超声研究的造影剂,其包括由非蛋白质交联或聚合的两亲部分包封的气体或气体前体的微泡。
-
公开(公告)号:US20020090341A1
公开(公告)日:2002-07-11
申请号:US09975317
申请日:2001-10-12
申请人: NYCOMED IMAGING AS
发明人: Alan David Watson , Michael Wendland , Per Jynge , Jan Olof Karlsson , Heidi Brurok , Pal Rongved , Maythem Saeed
IPC分类号: A61K049/00
CPC分类号: G01R33/5601 , A61K49/06
摘要: The invention provides a method of detecting myocardial ischemia in a human or a non-human body, said method comprising administering to said body a physiologically acceptable manganese complex or salt thereof, subjecting said body to a magnetic resonance imaging procedure capable of generating images with time intervals of less than 0.5 seconds and thereafter providing a series of images of the myocardium of said body whereby to identify regions of abnormal blood flow. The method in accordance with the invention is of use not only in detecting myocardial ischemia, but also in discriminating between reversibly and irreversibly injured myocardial tissues, thereby providing important information about myocardial viability, e.g. during or following a severe heart attack or coronary occlusion. The method of the invention also provides an effective means of monitoring reperfusion of the myocardium.
摘要翻译: 本发明提供了一种在人或非人体中检测心肌缺血的方法,所述方法包括向所述身体施用生理上可接受的锰络合物或其盐,使所述身体进行能够随时间产生图像的磁共振成像程序 间隔小于0.5秒,此后提供所述身体的心肌的一系列图像,从而识别异常血流的区域。 根据本发明的方法不仅用于检测心肌缺血,还用于区分可逆和不可逆损伤的心肌组织,从而提供关于心肌存活力的重要信息,例如, 在严重心脏病发作或冠状动脉闭塞期间或之后。 本发明的方法还提供了监测心肌再灌注的有效手段。
-
-
-
-
-
-
-
-
-